Ebumab Holding ApS: Financial statements 2023
CVR: 39807556
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Ebumab Holding ApS (CVR 39807556) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -22,743 and a net result of DKK 171,331 compared with DKK 100,146 the year before. Equity in the 2023 report amounted to DKK 5,644,448. The solvency ratio was 98.2%.
- Revenue
- DKK 0
- Gross Profit
- DKK -22,743
- Profit/Loss
- DKK 171,331
- Equity
- DKK 5,644,448
- Total Assets
- DKK 5,745,229
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | 0 | -23K | 171K | 5.6M | 0 |
| 2022 | 0 | -57K | 100K | 5.5M | 0 |
| 2021 | 0 | -45K | 163K | 5.4M | 0 |
| 2020 | 785K | 392K | -337K | 5.2M | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of September 1, 2023, Mads Nikolaj Behrndt-Eriksen has joined the board of directors of Ebumab Holding ApS.
Ebumab Holding ApS has published its annual report for 2022. Revenue came to DKK 0, and the net result was DKK 100,146.
As of August 24, 2023, Slotsgade Revision ApS has been appointed auditor of Ebumab Holding ApS.
As of August 24, 2023, Hans Heugh Wandall has joined the board of directors of Ebumab Holding ApS.
As of August 24, 2023, Johan Henrik Faber has joined the board of directors of Ebumab Holding ApS.
As of August 24, 2023, Søren Erik Bjørn has joined the board of directors of Ebumab Holding ApS.
As of August 24, 2023, Thomas Dal Stenfeldt Batchelor has joined the board of directors of Ebumab Holding ApS.
As of August 24, 2023, Hans Heugh Wandall is registered as director of Ebumab Holding ApS.
As of August 24, 2023, Johan Henrik Faber is registered as director of Ebumab Holding ApS.
As of August 15, 2023, Slotsgade Revision ApS has stepped down as auditor of Ebumab Holding ApS.
About Ebumab Holding ApS
Ebumab Holding ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2018. The company is registered under the industry Ikke-finansielle hovedsæders aktiviteter. The management consists of Hans Heugh Wandall and Johan Henrik Faber. The board consists of Hans Heugh Wandall (chair), Johan Henrik Faber, Mads Nikolaj Behrndt-Eriksen and Søren Erik Bjørn. The company's owners include Wandall Holding ApS, Johan H. Faber ApS and Batchelor Holding ApS. The company has 1 employee (2024). In 2025, the company reported a gross profit of DKK -86,871 and a net result of DKK 75,634,949 compared with DKK -39,197 the year before. Equity in the 2025 report amounted to DKK 5,684,083.